Research On Financing Strategy Of Suzhou At Phararmaceutical R&D Company

As a strategic emerging industry defined in our country's 12 th Five-Year Plan,the pharmaceutical industry is also a key development area of "Made in China 2025".Under the unprecedented attention of the state to the pharmaceutical industry,the status of the pharmaceutical industry has been constantly improved.In addition,the market demand for medicine is a rigid demand.Because of our large population,under the background of accelerated ageing,environmental deterioration and changes in people's lifestyle,human diseases have gradually transited from infectious diseases to chronic diseases.The market size of the pharmaceutical industry has been further increased.The pharmaceutical industry is of great significance for promoting human welfare and improving the quality of economic development.As we all know,R&D innovation in the pharmaceutical industry is not easy.It has the characteristics of "high investment,high risk,high return and long cycle".High investment means that R&D enterprises need to continuously increase capital investment,so enterprises very much hope to have enough funds to complete such R&D innovation.R&D enterprises have a high demand for specialization.The demand for scientific and technological talents is much higher than that of other enterprises,but it is also subject to the funds of enterprises,which often fails to attract high-tech talents.This requires enterprises to have a good financial environment to adapt to and promote the development of enterprises,and at the same time cannot be separated from the support of the state and government.This paper takes Suzhou AT Pharmaceutical Science and Technology Research and Development Company as the research object,analyses the fund demand and financing status of the company,and makes a very clear analysis of the enterprise's fund gap and causes,combines the development environment of domestic and foreign biomedical industry with the characteristics of AT company,deeply studies the financing problems of AT company,and puts forward solutions and implementation safeguards.